Xinfan Li

Company: Mabplex

Job title: Chief Operating Officer

Bio:

• D. in Molecular Biology and Biochemistry from Peking University in Beijing China
• Post-Doctorate at Harvard University
• Her work has directly impacted more than 20 product approvals by the FDA
• Holds multiple patents and publications in Antibody Drug Conjugate preparation and purification technologies
• She is an expert in viral clearance

 

Seminars:

Key CMC Considerations for Integrated ADC Development to Production 11:40 am

Integrated conjugate development approach at Mabplex including early stage linker-toxin combination evaluation Implementation of new technology or continuous improvement Time line fits customer needs based on risk assessmentRead more

day: Day One